Inventors: Ruchi Jain Dey, Willam Ramses Bishai

This project aims to develop a Mycobacterium bovis BCG vaccine enhanced with an endogenous STING agonist adjuvant to improve its efficacy against tuberculosis. By incorporating the STING agonist, the vaccine is designed to enhance the immune response and provide better protection against TB. The research focuses on optimizing vaccine formulations.